| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Cornell Scott-Hill Health Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Cornell Scott-Hill Health Center is based in New Haven, CT. You can find more information on Cornell Scott-Hill Health Center at www.hillhealthcenter.com
Janet, Jenner, and Suggs LLC is a Pikesville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MedCost LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Winston Salem, NC. To find more information about MedCost LLC, please visit www.medcost.com
Complete Homecare Inc is a Tonawanda, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.